Characteristic | Before Propensity Score Matching | After Propensity Score Matching | ||||
---|---|---|---|---|---|---|
No IRINC (n = 361) | IRINC (n = 877) | SMD (%) | No IRINC (n = 341) | IRINC (n = 341) | SMD (%) | |
Admission | Â | Â | Â | Â | Â | Â |
 Female | 112 (31.0) | 241 (27.5) | 7.8 | 102 (29.9) | 96 (28.2) | 3.9 |
 Age, mean (SD) | 59.34 (17.70) | 62.11 (17.18) | 15.9 | 59.91 (17.68) | 59.57 (17.52) | 2.0 |
 Diagnostic |  |  | 12.1 |  |  | 6.5 |
  Medical | 211 (58.4) | 546 (62.3) |  | 202 (59.2) | 191 (56.0) |  |
  Surgical | 106 (29.4) | 211 (24.1) |  | 96 (28.2) | 104 (30.5) |  |
  Traumatology | 44 (12.2) | 120 (13.7) |  | 43 (12.6) | 46 (13.5) |  |
 APACHE II score, mean (SD) | 18.58 (6.79) | 20.88 (7.18) | 32.9 | 18.91 (6.71) | 19.28 (6.46) | 5.7 |
Chronic comorbidity | Â | Â | Â | Â | Â | Â |
 Chronic Obstructive Pulmonary Disease | 28 (7.8) | 102 (11.6) | 13.1 | 28 (8.2) | 26 (7.6) | 2.2 |
 Diabetes Mellitus | 67 (18.6) | 161 (18.4) | 0.5 | 62 (18.2) | 56 (16.4) | 4.7 |
 Malignancy | 36 (10.0) | 89 (10.1) | 0.6 | 34 (10.0) | 38 (11.1) | 3.8 |
 Renal insufficiency | 69 (19.1) | 143 (16.3) | 7.4 | 63 (18.5) | 66 (19.4) | 2.2 |
CVC removed day with suspected CRBSI | Â | Â | Â | Â | Â | Â |
 Treatment Interventions |  |  |  |  |  |  |
  Vasoconstrictor Agents | 167 (46.3) | 481 (54.8) | 17.2 | 159 (46.6) | 168 (49.3) | 5.3 |
  Corticosteroids | 66 (18.3) | 149 (17.0) | 3.4 | 63 (18.5) | 56 (16.4) | 5.4 |
  Anticoagulant | 106 (29.4) | 291 (33.2) | 8.2 | 99 (29.0) | 97 (28.4) | 1.3 |
  Antibiotics | 252 (69.8) | 658 (75.0) | 11.7 | 237 (69.5) | 232 (68.0) | 3.2 |
  Renal replacement therapy | 122 (33.8) | 280 (31.9) | 4.0 | 115 (33.7) | 108 (31.7) | 4.4 |
  Mechanical ventilation | 217 (60.1) | 559 (63.7) | 7.5 | 205 (60.1) | 201 (58.9) | 2.4 |
Catheter information | Â | Â | Â | Â | Â | Â |
 Site |  |  | 16.8 |  |  | 4.3 |
  Jugular | 203 (56.2) | 510 (58.2) |  | 193 (56.6) | 188 (55.1) |  |
  Subclavian | 79 (21.9) | 229 (26.1) |  | 78 (22.9) | 77 (22.6) |  |
  Femoral | 79 (21.9) | 138 (15.7) |  | 70 (20.5) | 76 (22.3) |  |
 Catheter-days, days | 9.06 (4.92) | 9.45 (4.93) | 8.0 | 9.13 (4.95) | 9.60 (5.13) | 9.4 |
Clinical symptoms and status | Â | Â | Â | Â | Â | Â |
 Temperature, mean (SD) | 38.22 (0.84) | 38.38 (0.81) | 19.2 | 38.24 (0.84) | 38.19 (0.82) | 6.0 |
 Mean Arterial Pressure, mean (SD) | 81.70 (17.99) | 77.63 (16.20) | 23.8 | 81.10 (17.51) | 80.52 (16.83) | 3.4 |
 SOFA, mean (SD) | 10.17 (3.38) | 10.99 (3.80) | 23.0 | 10.23 (3.40) | 10.16 (3.62) | 2.1 |
 Acute Respiratory Distress Syndrome | 64 (17.7) | 122 (13.9) | 10.5 | 56 (16.4) | 60 (17.6) | 3.1 |
 Catheter-related bloodstream infections | 46 (12.7) | 168 (19.2) | 17.6 | 45 (13.2) | 40 (11.7) | 4.4 |
Laboratory results, mean (SD) | Â | Â | Â | Â | Â | Â |
 Blood glucose level, mmol/L | 9.93 (3.74) | 10.42 (3.79) | 13.1 | 10.00 (3.79) | 9.76 (3.49) | 6.7 |
 Leukocyte Count, × 109/L | 13.92 (7.25) | 14.86 (8.31) | 12.0 | 14.07 (7.32) | 13.96 (7.18) | 1.5 |
 Neutrophils, × 109/L | 11.68 (7.51) | 12.49 (7.87) | 10.5 | 11.83 (7.63) | 11.52 (6.06) | 4.5 |
 Plasma procalcitonin, ug/L | 6.24 (44.49) | 6.03 (14.40) | 0.6 | 4.08 (11.30) | 5.08 (13.00) | 8.2 |
 Creatinine, µmol/L | 145.73 (147.18) | 146.57 (135.23) | 0.6 | 147.58 (148.19) | 139.71 (139.22) | 5.5 |
 Activated Partial Thromboplastin Time, seconds | 41.60 (15.66) | 40.15 (20.73) | 7.9 | 41.77 (16.05) | 41.25 (22.07) | 2.7 |
 International Normalized Ratio | 1.26 (1.00) | 1.34 (0.76) | 8.6 | 1.27 (1.03) | 1.34 (0.80) | 6.9 |
 Platelet, × 109/L | 203.83 (144.12) | 184.36 (120.54) | 14.7 | 199.67 (143.41) | 195.58 (118.79) | 3.1 |
 Plasma total bilirubin, μmol/L | 34.82 (66.65) | 38.39 (63.39) | 5.5 | 33.59 (64.13) | 32.09 (50.53) | 2.6 |
 PaO2, mmHg | 113.40 (36.44) | 109.05 (38.17) | 11.6 | 112.87 (36.82) | 113.55 (42.18) | 1.7 |
 Lactic acid, mmol/L | 2.05 (2.25) | 2.19 (2.91) | 5.4 | 2.06 (2.31) | 2.04 (2.98) | 1.0 |